20th October 2003

Lane Earl Cox add four new accounts

Lane Earl Cox has had a busy Summer resulting in four new accounts:

UCB Pharma

The agency has been appointed to handle UCB Pharma's anti-epileptic drug Keppra. This followed the successful global pitch which LEC's international network, TBWA\WorldHealth, won earlier in the year. Lane Earl Cox will be contributing to the new global campaign as well as implementing it in the UK.

KCI International

KCI is a leading company in wound healing. Lane Earl Cox were selected to create and implement a new corporate image in major markets outside the USA. This will be followed up with new product launches as well as existing product revitalisations.

Solvay Healthcare

Lane Earl Cox worked with the TBWA\WorldHealth team in securing a global launch campaign for a new product. We have been subsequently appointed to handle the UK launch.

Norgine

Lane Earl Cox have produced new corporate materials for Norgine and are involved in a management consultancy role with the company

News Archive